The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

Learn how testosterone therapy works step by step, including diagnosis, treatment options, monitoring, and potential risks for men.

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

The maintenance dosing study is a Phase 1, randomized, double-blind, placebo-controlled trial designed to evaluate various dosing regimens, following initial weight loss achieved with weekly VK2735 ...

Dr. Sapolsky is a neuroscientist and primatologist. I was observing a 9-year-old male baboon in the Serengeti of East Africa one day in 1983. Baboon troops are very hierarchical, and this baboon was a ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

A Food and Drug Administration panel of health experts convened Wednesday to discuss and promote the health benefits of testosterone treatments for men. FDA Commissioner Martin Makary told Morning ...

This is T-rrific news for some men. Testosterone replacement therapy (TRT) has been historically difficult to get because it requires proof of consistently low testosterone levels along with symptoms ...

Testosterone therapy costs vary widely depending on the formulation you use, with injections generally the most affordable and pellets the most expensive. Even if insurance covers your testosterone ...